Inaugural Paul B. Hammond Award Goes To NIEHS Director
In a ceremony held Jan. 14, 2003, Kenneth Olden, PhD, director of the National Institute of Environmental Health Sciences (NIEHS) and the National Toxicology Program (NTP), received the inaugural Paul B. Hammond award. Dr. Paul B. Hammond served on the faculty of the UC Department of Environmental Health from 1972 until his death in 1998. His work in lead toxicity led to discoveries of the devastating effects that low levels of environmental lead has on children.
The first Paul B. Hammond award was presented to Dr. Olden in recognition of his efforts to improve childrens health in the United States. Under his leadership, the NIEHS is funding $4.2 million of research this year into childrens environmental health in Cincinnati. For the last 27 years, the NIEHS has provided annual funding of at least $1 million in Cincinnati for childhood lead poisoning research. The NIEHS has also funded one of twelve national Childrens Environmental Health Centers at Cincinnati Childrens Hospital Medical Center, under the direction of Bruce Lanphear, MD.
Dr. Olden was named the third director of the NIEHS and second director of the NTP in 1991. He is the first African-American to become director of one of the 18 institutes of the National Institutes of Health (NIH) in the over 100 year history of the agency.
Tags
Related Stories
Can new research improve the safety of AI therapy for teens?
December 5, 2025
The University of Cincinnati's Stephen Rush joined WVXU's Cincinnati Edition for a discussion on the growing trend of young people turning to artificial intelligence for mental health support and therapy.
Student-designed AI platform aims to match patients to specific cancer support groups
December 5, 2025
The University of Cincinnati is launching a clinical trial testing a student-designed, machine-learning powered platform to match patients with cancer to support groups specifically tailored to their needs and concerns.
What would expanded access to GLP-1s mean for the obesity rate?
December 4, 2025
The World Health Organization recently issued its first guidance on GLP-1 medications for adults with obesity — recommending long-term, continuous use when clinically appropriate. Malti Vij, MD, University of Cincinnati adjunct associate professor in the College of Medicine's Department of Internal Medicine, appeared on Cincinnati Edition on 91.7 WVXU News to discuss GLP-1s and what expanded insurance coverage of the medications might mean for Americans.